Biovail reduces quarterly guidance

Article Abstract:

Mississauga-based Biovail Corp. has cut its third-quarter guidance, after a fatal traffic accident involving a tractor-trailer loaded with millions of the company's anti-depression pills. The wreck prevented a shipment of Wellbutrin XL tablets worth $15-million to $20-million from reaching GlaxoSmithKline PLC, which is Biovail's marketing partner in the venture.

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly:

Biovail faces possible FDA hitch to pain drug

Article Abstract:

The US Food and Drug Administration that has asked Biovail Corp. for more clinical information about its blockbuster pain reliever, is reported. The Mississauga-based company has not disclosed what else it has to submit to the agency for final approval of its Ralivia ER drug.

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly:

QLT plans $104-million stock buyback

Article Abstract:

The impact of second quarter 2006 profit downfall for QLT Inc., which proposes $104 million stock buyback, is discussed.

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly: